Population pharmacokinetic and pharmacodynamic modeling of transformed binary effect data of triflusal in healthy Korean male volunteers: a randomized, open-label, multiple dose, crossover study-Reference-Cited by-同舟云学术

Population pharmacokinetic and pharmacodynamic modeling of transformed binary effect data of triflusal in healthy Korean male volunteers: a randomized, open-label, multiple dose, crossover study

Published:2014-12 Issue:1 Volume:15 Page:
ISSN:2050-6511
Container-title:BMC Pharmacology and Toxicology
language:en
Short-container-title:BMC Pharmacol Toxicol

Author:

Park Sung Min,Lee Joomi,Seong Sook Jin,Park Jong Gwang,Gwon Mi-Ri,Lim Mi-sun,Lee Hae Won,Yoon Young-Ran,Yang Dong Heon,Kwon Kwang-Il,Han Seunghoon

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1186/2050-6511-15-75.pdf

Reference21 articles.

1. Matias-Guiu J, Ferro JM, Alvarez-Sabin J, Torres F, Jiménez MD, Lago A, Melo T: Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial. Stroke. 2003, 34: 840-848. 10.1161/01.STR.0000063141.24491.50.

2. McNeely W, Goa KL: Triflusal. Drugs. 1998, 7: 823-833.

3. Valle M, Barbanoj MJ, Donner A, Izquierdo I, Herranz U, Klein N, Eichler HG, Müller M, Brunner M: Access of HTB, main metabolite of triflusal, to cerebrospinal fluid in healthy volunteers. Eur J Clin Pharmacol. 2005, 61: 103-111. 10.1007/s00228-004-0887-0.

4. Lee HW, Lim MS, Seong SJ, Lee J, Park J, Seo JJ, Yun HY, Baek IH, Kwon KI, Yoon YR: A phase I study to characterize the multiple-dose pharmacokinetics, pharmacodynamics and safety of new enteric-coated triflusal formulations in healthy male volunteers. Expert Opin Drug Metab Toxicol. 2011, 7: 1471-1479. 10.1517/17425255.2011.630661.

5. Anninos H, Andrikopoulos G, Pastromas S, Sakellariou D, Theodorakis G, Vardas P: Triflusal: an old drug in modern antiplatelet therapy. Review of its action, use, safety and effectiveness. Hellenic J Cardiol. 2009, 50: 199-207.